Incidence of Lyme Borreliosis in Europe from National Surveillance Systems (2005

Incidence of Lyme Borreliosis in Europe from National Surveillance Systems (2005–2020)

Published:2023-04-01 Issue:4 Volume:23 Page:156-171
ISSN:1530-3667
Container-title:Vector-Borne and Zoonotic Diseases
language:en
Short-container-title:Vector-Borne and Zoonotic Diseases

Author:

Burn Leah¹,Tran Thao Mai Phuong²,Pilz Andreas³,Vyse Andrew⁴,Fletcher Mark A.⁵,Angulo Frederick J.⁶,Gessner Bradford D.⁶,Moïsi Jennifer C.⁷,Jodar Luis⁶,Stark James H.⁶

Affiliation:

1. P95 Pharmacovigilance & Epidemiology, Princeton, New Jersey, USA.

2. P95 Pharmacovigilance & Epidemiology, Leuven, Belgium.

3. Pfizer Global Medical Affairs, Vaccines, Vienna, Austria.

4. Pfizer Vaccines Medical, Walton Oaks, Surrey, United Kingdom.

5. Pfizer Emerging Markets Medical Affairs, Vaccines, Paris, France.

6. Pfizer Vaccines Medical Development, Scientific and Clinical Affairs, Collegeville, Pennsylvania, USA.

7. Pfizer Medical Development, Scientific and Clinical Affairs, Vaccines, Paris, France.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Infectious Diseases,Microbiology

Link

https://www.liebertpub.com/doi/pdf/10.1089/vbz.2022.0071

Reference25 articles.

1. Diagnostic challenges of early Lyme disease: Lessons from a community case series

2. Comparison of national surveillance systems for Lyme disease in humans in Europe and North America: a policy review

3. Epidemiological situation of Lyme borreliosis in Belgium, 2003 to 2012

4. Recent Progress in Lyme Disease and Remaining Challenges

5. Laboratory Diagnosis of Lyme Borreliosis

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of symptomatic Borrelia burgdorferi sensu lato infection in Romania, 2018−2023;Parasites & Vectors;2024-09-05

2. Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies;The Lancet Infectious Diseases;2024-09

3. Tick-Borne Diseases in Sub-Saharan Africa: A Systematic Review of Pathogens, Research Focus, and Implications for Public Health;Pathogens;2024-08-17

4. Central nervous system manifestations in rheumatic diseases;Rheumatology International;2024-08-13

5. Prevalence of tick-borne bacterial pathogens in Germany—has the situation changed after a decade?;Frontiers in Cellular and Infection Microbiology;2024-07-18